Effect of Cabazitaxel on the QTc Interval in Cancer Patients

Clinical trial NCT01087021 · COMPLETED

Trial details

NCT number: NCT01087021
Sponsor: Sanofi
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Neoplasms, Malignant

Start date: 2010-03-01
Primary completion: 2011-04-01
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.